Summary
The effect of intramuscular Digoxin on 20 cases is analysed. The glycoside is rapidly absorbed from muscle, and the results indicate that the intramuscular route is an efficient substitute for intravenous therapy when urgent parenteral digitalisation is required. In undigitalised adults a suitable initial dose is 1 mg. and maximum therapeutic effect is likely within six hours. In auricular fibrillation initial ventricular slowing may be mainly vagal.
Concurrent mercurial diuresis may enhance the therapeutic effect of intramuscular Digoxin probably due to increased absorption. Intramuscular Digoxin may be painful and this may limit its value for maintenance therapy. The pain appears to be due to a direct action of Digoxin on voluntary muscle.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cattell, M., and Goodell, H. (1937).Science, 86, 106.
Fletcher, E., and Brennan, C. F.Brit. Heart J. (in Press).
Fletcher, E., and Brennan, C. F. (1937)Brit. Med. J.
Hatcher, R. A., and Weiss, S. (1922).Arch. int. Med., 29, 690.
Lown, B., and Levine, S. A. (1955).Current Concepts of Digitalis Therapy, Churchill, London.
Rose, O. A., Batterman, R. C. and de Graff, A. C. (1942).Amer. Heart J., 24, 435.
Sampson, J. J., Alberton, E. C., and Kondo, B. (1943).Amer. Heart J., 26, 164.
Scherf, D., and Schott, A. (1953).Extrasystoles and Allied Arrhythmias, Heinemann, London.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fletcher, E., Brennan, C.F. Experience with intramuscular Digoxin. Ir J Med Sci 33, 273–280 (1958). https://doi.org/10.1007/BF02951580
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02951580